-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L8rSOJ6EqK9lV18AA5697n9/g32J6uUl9U8NMBoSM/F0jyy5Q0LasqHmpM4osWrp bC8rKxSSiK9xedzuJr/UAg== 0000742112-10-000008.txt : 20100330 0000742112-10-000008.hdr.sgml : 20100330 20100330124904 ACCESSION NUMBER: 0000742112-10-000008 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100330 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20100330 DATE AS OF CHANGE: 20100330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 10712933 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 8-K 1 form8k.htm form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

 
Date of report (Date of earliest event reported):  March 30, 2010
 
 
INVACARE CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 Ohio
 001-15103
95-2680965
(State or other jurisdiction of
incorporation or organization)
 (Commission File Number)
(IRS Employer Identification No)
 
  
 
One Invacare Way, P.O. Box 4028, Elyria, Ohio  44036
(Address of principal executive offices, including zip code) 
 
  (440) 329-6000
  (Registrant's telephone number, including area code)
  
_____________________________________________________________
 (Former name, former address and former fiscal year, if changed since last report)
                       
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 
 
 

Item 7.01.                      Regulation FD Disclosure.
 
On March 30, 2010, President Obama signed the Reconciliation bill which amends the Health Care Reform bill signed by the President on March 23, 2010.  The Reconciliation bill includes a new tax on U.S. sales of medical device manufacturers or importers, such as Invacare Corporation (the “Company”).  The law would impose a yearly 2.3% sales-based or excise tax on medical device manufacturers or importers starting January 1, 2013. The excise tax would be deductible by the manufacturer or importer on its federal tax return.  The excise tax would not apply to medical devices that the Secretary of Treasury determines are generally purchased by the general public at retail for individual use.
 
Once there is a clear understanding of what specific medical device products will be covered by the excise tax, the Company will evaluate all of its available options to offset the impact of the proposed tax on the Company’s financial results in 2013, including possible price increases on the relevant products.
 



 
 
 

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Invacare Corporation
 
(Registrant)
   
Date:  March 30, 2010
  
 
/s/ Anthony C. LaPlaca
 
Anthony C. LaPlaca
Senior Vice President and General Counsel
   
   
   


-----END PRIVACY-ENHANCED MESSAGE-----